chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Biopsy heart abnormal, Cardiac index, Cardiogenic shock, Cardiomyopathy
Clinical narrative: Patient received a second heart transplant on 7/19/21 admitted on 1/27/22 with cardiogenic shock considered to be secondary to acute inflammatory cardiomyopathy, possible mycocarditis, and rejection. She received 3rd Moderna COVID vaccine on 1/13/2022. She was admitted 2 weeks later on 1/27/22, presenting with chest and abdominal pain, cough, and dyspnea. Her ECHO on 1/27/22 demonstrated a cardiac index of 1.3 L/min/m2 and LVEF = 20-25%; the left ventricular systolic function was severely reduced; the right ventricular systolic function was severely reduced with   moderate to severe mitral regurgitation and severe tricuspid regurgitation. In comparison, her ECHO from 1/5/22, demonstrated a cardiac index of 3.0 L/min/m2 and LVEF = 55%; the left ventricular systolic function was borderline reduced; the right ventricle was normal in size and function with structurally normal mitral valve with mild regurgitation, and the right ventricle was normal in size and function. She also had a PEA arrest on 1/27/22 with ROSC, was transferred to the ICU and a mechanical circulatory support (Impella) was placed with continued dobutamine 5 mcg/kg/min. Biopsy from 1/27/22 demonstrated acute cellular rejection Grade 2.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Cough, Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: Patient received a second heart transplant on 7/19/21 admitted on 1/27/22 with cardiogenic shock considered to be secondary to acute inflammatory cardiomyopathy, possible mycocarditis, and rejection. She received 3rd Moderna COVID vaccine on 1/13/2022. She was admitted 2 weeks later on 1/27/22, presenting with chest and abdominal pain, cough, and dyspnea. Her ECHO on 1/27/22 demonstrated a cardiac index of 1.3 L/min/m2 and LVEF = 20-25%; the left ventricular systolic function was severely reduced; the right ventricular systolic function was severely reduced with   moderate to severe mitral regurgitation and severe tricuspid regurgitation. In comparison, her ECHO from 1/5/22, demonstrated a cardiac index of 3.0 L/min/m2 and LVEF = 55%; the left ventricular systolic function was borderline reduced; the right ventricle was normal in size and function with structurally normal mitral valve with mild regurgitation, and the right ventricle was normal in size and function. She also had a PEA arrest on 1/27/22 with ROSC, was transferred to the ICU and a mechanical circulatory support (Impella) was placed with continued dobutamine 5 mcg/kg/min. Biopsy from 1/27/22 demonstrated acute cellular rejection Grade 2.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Left ventricular dysfunction, Mitral valve incompetence, Pulseless electrical activity, Right ventricular dysfunction
Clinical narrative: Patient received a second heart transplant on 7/19/21 admitted on 1/27/22 with cardiogenic shock considered to be secondary to acute inflammatory cardiomyopathy, possible mycocarditis, and rejection. She received 3rd Moderna COVID vaccine on 1/13/2022. She was admitted 2 weeks later on 1/27/22, presenting with chest and abdominal pain, cough, and dyspnea. Her ECHO on 1/27/22 demonstrated a cardiac index of 1.3 L/min/m2 and LVEF = 20-25%; the left ventricular systolic function was severely reduced; the right ventricular systolic function was severely reduced with   moderate to severe mitral regurgitation and severe tricuspid regurgitation. In comparison, her ECHO from 1/5/22, demonstrated a cardiac index of 3.0 L/min/m2 and LVEF = 55%; the left ventricular systolic function was borderline reduced; the right ventricle was normal in size and function with structurally normal mitral valve with mild regurgitation, and the right ventricle was normal in size and function. She also had a PEA arrest on 1/27/22 with ROSC, was transferred to the ICU and a mechanical circulatory support (Impella) was placed with continued dobutamine 5 mcg/kg/min. Biopsy from 1/27/22 demonstrated acute cellular rejection Grade 2.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Temporary mechanical circulatory support, Transplant rejection, Tricuspid valve incompetence
Clinical narrative: Patient received a second heart transplant on 7/19/21 admitted on 1/27/22 with cardiogenic shock considered to be secondary to acute inflammatory cardiomyopathy, possible mycocarditis, and rejection. She received 3rd Moderna COVID vaccine on 1/13/2022. She was admitted 2 weeks later on 1/27/22, presenting with chest and abdominal pain, cough, and dyspnea. Her ECHO on 1/27/22 demonstrated a cardiac index of 1.3 L/min/m2 and LVEF = 20-25%; the left ventricular systolic function was severely reduced; the right ventricular systolic function was severely reduced with   moderate to severe mitral regurgitation and severe tricuspid regurgitation. In comparison, her ECHO from 1/5/22, demonstrated a cardiac index of 3.0 L/min/m2 and LVEF = 55%; the left ventricular systolic function was borderline reduced; the right ventricle was normal in size and function with structurally normal mitral valve with mild regurgitation, and the right ventricle was normal in size and function. She also had a PEA arrest on 1/27/22 with ROSC, was transferred to the ICU and a mechanical circulatory support (Impella) was placed with continued dobutamine 5 mcg/kg/min. Biopsy from 1/27/22 demonstrated acute cellular rejection Grade 2.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Angiogram pulmonary normal, Anxiety, Blood creatinine increased
Clinical narrative: PROVIDER PROGRESS NOTE 2/8/2022 LOS: 7    BRIEF SUMMARY: 76 y.o. male with past medical history of CAD, hypertension, hyperlipidemia, interstitial lung disease and RA on chronic mycophenolate and prednisone who was admitted on 2/1/2022 with shortness of breath, cough, myalgias and malaise, found to have acute hypoxic respiratory failure 2/2 COVID PNA. Rapid escalation of oxygen needs, currently on near maximal support on HFNC; not tolerating BiPAP.   ASSESSMENT/PLAN:  Acute hypoxic respiratory failure likely due to Covid?19 pneumonia Hx interstitial lung disease Symptomatic x1 week.  Fully vaccinated and booster dose but risk factors of immunosuppression on MMF and prednisone. CXR on admission shows multiple bilateral airspace opacities, combination of chronic fibrosis and pneumonia. Pro-Cal not suggestive of superimposed bacterial PNA. D-dimer elevated, so obtained CT angiogram which was negative for PE. Started on dexamethasone 6 mg daily, however escalated to HFNC on 2/4 so switched to methylprednisolone 125 mg IV. Maintaining Spo2, however due to increased WOB, started on BiPAP 02/07, however did not tolerate it well. CXR 02/08 with interval worsening of patchy opacities, no focal consolidation.  - continue steroids                 - dexamethasone 6 mg daily (2/1-2/3)                - methylprednisolone 125 mg IV (2/4-TBD) - Full dose Lovenox for prophylactic anticoagulation - Encourage proning as able  - full barrier precaution - start BiPAP due to increased WOB (2/07)                 - hydroxyzine 25-50 mg PO q6H PRN and ativan 0.5 mg IV q6H PRN for anxiety - furosemide 40 mg IV x 1 - Discussed w/ pharm and ID not candidate Toci/ baracitinib - will discuss with team regarding possible transfer   Hx CAD s/p BMS LAD 2008 NSTMEI Trop negative. No chest pain.  - Resume PTA statin   Dyslipidemia - Continue PTA statin.   Hx of HTN - No scheduled BP meds. BP is appropriate.    Mild AKI, resolved  Cr 1.30 on admission, down-trended to 0.8-0.9. Hx of CKD2 per review of EMR. - Avoid nephrotoxins - BMP qAM   Rheumatoid arthritis - holding PTA mycophenolate and prednisone 10 mg daily  - On IV solumedrol as above    Cerebral aneurysm s/p clipping   Hypothyroidism - PTA levothyroxine 50 mcg daily    BPH - PTA tamsulosin
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Condition aggravated, Cough, Dyslipidaemia
Clinical narrative: PROVIDER PROGRESS NOTE 2/8/2022 LOS: 7    BRIEF SUMMARY: 76 y.o. male with past medical history of CAD, hypertension, hyperlipidemia, interstitial lung disease and RA on chronic mycophenolate and prednisone who was admitted on 2/1/2022 with shortness of breath, cough, myalgias and malaise, found to have acute hypoxic respiratory failure 2/2 COVID PNA. Rapid escalation of oxygen needs, currently on near maximal support on HFNC; not tolerating BiPAP.   ASSESSMENT/PLAN:  Acute hypoxic respiratory failure likely due to Covid?19 pneumonia Hx interstitial lung disease Symptomatic x1 week.  Fully vaccinated and booster dose but risk factors of immunosuppression on MMF and prednisone. CXR on admission shows multiple bilateral airspace opacities, combination of chronic fibrosis and pneumonia. Pro-Cal not suggestive of superimposed bacterial PNA. D-dimer elevated, so obtained CT angiogram which was negative for PE. Started on dexamethasone 6 mg daily, however escalated to HFNC on 2/4 so switched to methylprednisolone 125 mg IV. Maintaining Spo2, however due to increased WOB, started on BiPAP 02/07, however did not tolerate it well. CXR 02/08 with interval worsening of patchy opacities, no focal consolidation.  - continue steroids                 - dexamethasone 6 mg daily (2/1-2/3)                - methylprednisolone 125 mg IV (2/4-TBD) - Full dose Lovenox for prophylactic anticoagulation - Encourage proning as able  - full barrier precaution - start BiPAP due to increased WOB (2/07)                 - hydroxyzine 25-50 mg PO q6H PRN and ativan 0.5 mg IV q6H PRN for anxiety - furosemide 40 mg IV x 1 - Discussed w/ pharm and ID not candidate Toci/ baracitinib - will discuss with team regarding possible transfer   Hx CAD s/p BMS LAD 2008 NSTMEI Trop negative. No chest pain.  - Resume PTA statin   Dyslipidemia - Continue PTA statin.   Hx of HTN - No scheduled BP meds. BP is appropriate.    Mild AKI, resolved  Cr 1.30 on admission, down-trended to 0.8-0.9. Hx of CKD2 per review of EMR. - Avoid nephrotoxins - BMP qAM   Rheumatoid arthritis - holding PTA mycophenolate and prednisone 10 mg daily  - On IV solumedrol as above    Cerebral aneurysm s/p clipping   Hypothyroidism - PTA levothyroxine 50 mcg daily    BPH - PTA tamsulosin
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fibrin D dimer increased, Fibrosis, Lung opacity, Malaise
Clinical narrative: PROVIDER PROGRESS NOTE 2/8/2022 LOS: 7    BRIEF SUMMARY: 76 y.o. male with past medical history of CAD, hypertension, hyperlipidemia, interstitial lung disease and RA on chronic mycophenolate and prednisone who was admitted on 2/1/2022 with shortness of breath, cough, myalgias and malaise, found to have acute hypoxic respiratory failure 2/2 COVID PNA. Rapid escalation of oxygen needs, currently on near maximal support on HFNC; not tolerating BiPAP.   ASSESSMENT/PLAN:  Acute hypoxic respiratory failure likely due to Covid?19 pneumonia Hx interstitial lung disease Symptomatic x1 week.  Fully vaccinated and booster dose but risk factors of immunosuppression on MMF and prednisone. CXR on admission shows multiple bilateral airspace opacities, combination of chronic fibrosis and pneumonia. Pro-Cal not suggestive of superimposed bacterial PNA. D-dimer elevated, so obtained CT angiogram which was negative for PE. Started on dexamethasone 6 mg daily, however escalated to HFNC on 2/4 so switched to methylprednisolone 125 mg IV. Maintaining Spo2, however due to increased WOB, started on BiPAP 02/07, however did not tolerate it well. CXR 02/08 with interval worsening of patchy opacities, no focal consolidation.  - continue steroids                 - dexamethasone 6 mg daily (2/1-2/3)                - methylprednisolone 125 mg IV (2/4-TBD) - Full dose Lovenox for prophylactic anticoagulation - Encourage proning as able  - full barrier precaution - start BiPAP due to increased WOB (2/07)                 - hydroxyzine 25-50 mg PO q6H PRN and ativan 0.5 mg IV q6H PRN for anxiety - furosemide 40 mg IV x 1 - Discussed w/ pharm and ID not candidate Toci/ baracitinib - will discuss with team regarding possible transfer   Hx CAD s/p BMS LAD 2008 NSTMEI Trop negative. No chest pain.  - Resume PTA statin   Dyslipidemia - Continue PTA statin.   Hx of HTN - No scheduled BP meds. BP is appropriate.    Mild AKI, resolved  Cr 1.30 on admission, down-trended to 0.8-0.9. Hx of CKD2 per review of EMR. - Avoid nephrotoxins - BMP qAM   Rheumatoid arthritis - holding PTA mycophenolate and prednisone 10 mg daily  - On IV solumedrol as above    Cerebral aneurysm s/p clipping   Hypothyroidism - PTA levothyroxine 50 mcg daily    BPH - PTA tamsulosin
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Myalgia, Pneumonia, Positive airway pressure therapy, Procalcitonin
Clinical narrative: PROVIDER PROGRESS NOTE 2/8/2022 LOS: 7    BRIEF SUMMARY: 76 y.o. male with past medical history of CAD, hypertension, hyperlipidemia, interstitial lung disease and RA on chronic mycophenolate and prednisone who was admitted on 2/1/2022 with shortness of breath, cough, myalgias and malaise, found to have acute hypoxic respiratory failure 2/2 COVID PNA. Rapid escalation of oxygen needs, currently on near maximal support on HFNC; not tolerating BiPAP.   ASSESSMENT/PLAN:  Acute hypoxic respiratory failure likely due to Covid?19 pneumonia Hx interstitial lung disease Symptomatic x1 week.  Fully vaccinated and booster dose but risk factors of immunosuppression on MMF and prednisone. CXR on admission shows multiple bilateral airspace opacities, combination of chronic fibrosis and pneumonia. Pro-Cal not suggestive of superimposed bacterial PNA. D-dimer elevated, so obtained CT angiogram which was negative for PE. Started on dexamethasone 6 mg daily, however escalated to HFNC on 2/4 so switched to methylprednisolone 125 mg IV. Maintaining Spo2, however due to increased WOB, started on BiPAP 02/07, however did not tolerate it well. CXR 02/08 with interval worsening of patchy opacities, no focal consolidation.  - continue steroids                 - dexamethasone 6 mg daily (2/1-2/3)                - methylprednisolone 125 mg IV (2/4-TBD) - Full dose Lovenox for prophylactic anticoagulation - Encourage proning as able  - full barrier precaution - start BiPAP due to increased WOB (2/07)                 - hydroxyzine 25-50 mg PO q6H PRN and ativan 0.5 mg IV q6H PRN for anxiety - furosemide 40 mg IV x 1 - Discussed w/ pharm and ID not candidate Toci/ baracitinib - will discuss with team regarding possible transfer   Hx CAD s/p BMS LAD 2008 NSTMEI Trop negative. No chest pain.  - Resume PTA statin   Dyslipidemia - Continue PTA statin.   Hx of HTN - No scheduled BP meds. BP is appropriate.    Mild AKI, resolved  Cr 1.30 on admission, down-trended to 0.8-0.9. Hx of CKD2 per review of EMR. - Avoid nephrotoxins - BMP qAM   Rheumatoid arthritis - holding PTA mycophenolate and prednisone 10 mg daily  - On IV solumedrol as above    Cerebral aneurysm s/p clipping   Hypothyroidism - PTA levothyroxine 50 mcg daily    BPH - PTA tamsulosin
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin normal
Clinical narrative: PROVIDER PROGRESS NOTE 2/8/2022 LOS: 7    BRIEF SUMMARY: 76 y.o. male with past medical history of CAD, hypertension, hyperlipidemia, interstitial lung disease and RA on chronic mycophenolate and prednisone who was admitted on 2/1/2022 with shortness of breath, cough, myalgias and malaise, found to have acute hypoxic respiratory failure 2/2 COVID PNA. Rapid escalation of oxygen needs, currently on near maximal support on HFNC; not tolerating BiPAP.   ASSESSMENT/PLAN:  Acute hypoxic respiratory failure likely due to Covid?19 pneumonia Hx interstitial lung disease Symptomatic x1 week.  Fully vaccinated and booster dose but risk factors of immunosuppression on MMF and prednisone. CXR on admission shows multiple bilateral airspace opacities, combination of chronic fibrosis and pneumonia. Pro-Cal not suggestive of superimposed bacterial PNA. D-dimer elevated, so obtained CT angiogram which was negative for PE. Started on dexamethasone 6 mg daily, however escalated to HFNC on 2/4 so switched to methylprednisolone 125 mg IV. Maintaining Spo2, however due to increased WOB, started on BiPAP 02/07, however did not tolerate it well. CXR 02/08 with interval worsening of patchy opacities, no focal consolidation.  - continue steroids                 - dexamethasone 6 mg daily (2/1-2/3)                - methylprednisolone 125 mg IV (2/4-TBD) - Full dose Lovenox for prophylactic anticoagulation - Encourage proning as able  - full barrier precaution - start BiPAP due to increased WOB (2/07)                 - hydroxyzine 25-50 mg PO q6H PRN and ativan 0.5 mg IV q6H PRN for anxiety - furosemide 40 mg IV x 1 - Discussed w/ pharm and ID not candidate Toci/ baracitinib - will discuss with team regarding possible transfer   Hx CAD s/p BMS LAD 2008 NSTMEI Trop negative. No chest pain.  - Resume PTA statin   Dyslipidemia - Continue PTA statin.   Hx of HTN - No scheduled BP meds. BP is appropriate.    Mild AKI, resolved  Cr 1.30 on admission, down-trended to 0.8-0.9. Hx of CKD2 per review of EMR. - Avoid nephrotoxins - BMP qAM   Rheumatoid arthritis - holding PTA mycophenolate and prednisone 10 mg daily  - On IV solumedrol as above    Cerebral aneurysm s/p clipping   Hypothyroidism - PTA levothyroxine 50 mcg daily    BPH - PTA tamsulosin
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Computerised tomogram head, Computerised tomogram neck, Facial paralysis, Guillain-Barre syndrome
Clinical narrative: Numbness in hands. Numbness in feet spreading up through the legs. Shooting pain through the legs. Loss of strength in legs. Facial droop. Diagnosed in the hospital with Guillain-Barre' Syndrome (GBS).
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lumbar puncture, Magnetic resonance imaging spinal, Pain, Pain in extremity
Clinical narrative: Numbness in hands. Numbness in feet spreading up through the legs. Shooting pain through the legs. Loss of strength in legs. Facial droop. Diagnosed in the hospital with Guillain-Barre' Syndrome (GBS).
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Scan with contrast
Clinical narrative: Numbness in hands. Numbness in feet spreading up through the legs. Shooting pain through the legs. Loss of strength in legs. Facial droop. Diagnosed in the hospital with Guillain-Barre' Syndrome (GBS).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Shoulder joint pain on left arm and deltoid muscle soreness
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received Pfizer 12yr and up vaccine instead of 5-11yr old.  Dose was 0.3mg  patient did not have any adverse effects patient was discharged home after receiving vaccination
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, FLU4
Symptoms: Blood test abnormal, Erythema, Oropharyngeal pain, Pruritus, Rash
Clinical narrative: I have been breaking out in hives and rashes since January 12 2022.  The hives are very red and very itchy and it happens 3-4 times a day. The hives look like welts and scratches all over my body. The hives have been on my face. neck, chest, B/L breast, B/L arm, B/L legs, and stomach. I also get a one-sided sore throat that comes and goes. I have went to my PCP multipe times in the past month and two allergists. My blood work panel came back with the results of being allergic to nuts, soy, wheat, egg and milk. I changed my diet, and I am still breaking out in hives. I saw a new allergist and got the skin prick test performed and I tested negative for all food allergies. I am still suffering with hives 3-4 times aday
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, FLU4
Symptoms: Skin test, Skin test negative, Urticaria
Clinical narrative: I have been breaking out in hives and rashes since January 12 2022.  The hives are very red and very itchy and it happens 3-4 times a day. The hives look like welts and scratches all over my body. The hives have been on my face. neck, chest, B/L breast, B/L arm, B/L legs, and stomach. I also get a one-sided sore throat that comes and goes. I have went to my PCP multipe times in the past month and two allergists. My blood work panel came back with the results of being allergic to nuts, soy, wheat, egg and milk. I changed my diet, and I am still breaking out in hives. I saw a new allergist and got the skin prick test performed and I tested negative for all food allergies. I am still suffering with hives 3-4 times aday
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain in extremity
Clinical narrative: I experience fatigue and my arm was sore. I was nauseous.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache, Injection site pain, Lethargy, Nausea
Clinical narrative: Severe nausea and vomiting, fever, lethargy, stomach ache, headache, sore arm muscle at injection site
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Severe nausea and vomiting, fever, lethargy, stomach ache, headache, sore arm muscle at injection site
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test
Clinical narrative: Asymptomatic Positive
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Cough, Fatigue, Feeling cold, Rhinorrhoea
Clinical narrative: On 12/11/2021 the following day after having the 3rd Phizer booster shot I started having extreme tiredness, runny nose, cough and was very cold for no reason.  The following evening/morning of 12/12/2021 at around 3:30 am I was woken with a loud ringing in my ears. Louder in my left ear than the right but very loud in both.  It has been nonstop 24/7 ringing since then.  Over the last 8.5 weeks it has gone down from time to time but varies and always comes up.  It has left my right ear from time to time and I have had the tone change but there is always ringing and sometimes a hiss and cricket sound.  The sound sometimes sounds like it is in my left ear and middle of my head,  or right and left ears, or right, middle and left, and sometimes just the left.  On average is has been in both ears more often than not but recently mostly the left.  The volume sometimes goes down but always varies and can go back to the loudness I've experienced since this started.  I went to Medical Immediate Care on 12/23/201 and saw Dr.  I informed him of the tinnitus started a day a half after the booster.  He checked me and stated that I had congestion and prescribed me Claritin D, Flonase, and 20mg of Prednisone for 5 days starting the 3rd day after the other 2 medications.  He stated that there have been other reports of complications after taking the Covid vaccine but there is no information on when I may get over my symptoms.  He gave me a referral to an ENT for an immediate follow up.  I saw the ENT, on 12/28/21.  A separate audiologist gave me a hearing exam and stated my hearing is within the normal range.  She stated that my ears were clear and there was no sign of congestion or problems with my ears and that the hearing test showed a slight difference in my left ear than right but not significant and not the cause of the tinnitus.  She checked my mouth, neck, head and ears.  She found nothing with those checks. She stated my ears are healthy with no congestion or ETD.  She stated that there are other patients also having issues after Covid vaccines.  She stated there is no cure and couldn't tell me if or when the tinnitus will get better as the data regarding the Covid vaccines is too new and incomplete. She gave me a follow up to the ENT MD specialist there at Northwestern  but the closest appointment I could schedule is 5/23/2022.  She also suggested trying white noise and sound masking for relief along with a referral for accupuncture as she stated it has been helpful for some to deal with ongoing  tinnitus.   It is 2/08/2022 and it has been 8 weeks and 3 days since the tinnitus started 1.5 days after getting the Pfizer covid booster shot on 12/10/2021.  The tinnitus has been nonstop in my left ear sometimes in my right.  It has lessened at times but has not gone and sometimes is as loud as the first night.  It seems to increase and decrease in volume randomly.  This has greatly affected my health, wellbeing, and quality of life.  I am hoping it is going down overall over time.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: On 12/11/2021 the following day after having the 3rd Phizer booster shot I started having extreme tiredness, runny nose, cough and was very cold for no reason.  The following evening/morning of 12/12/2021 at around 3:30 am I was woken with a loud ringing in my ears. Louder in my left ear than the right but very loud in both.  It has been nonstop 24/7 ringing since then.  Over the last 8.5 weeks it has gone down from time to time but varies and always comes up.  It has left my right ear from time to time and I have had the tone change but there is always ringing and sometimes a hiss and cricket sound.  The sound sometimes sounds like it is in my left ear and middle of my head,  or right and left ears, or right, middle and left, and sometimes just the left.  On average is has been in both ears more often than not but recently mostly the left.  The volume sometimes goes down but always varies and can go back to the loudness I've experienced since this started.  I went to Medical Immediate Care on 12/23/201 and saw Dr.  I informed him of the tinnitus started a day a half after the booster.  He checked me and stated that I had congestion and prescribed me Claritin D, Flonase, and 20mg of Prednisone for 5 days starting the 3rd day after the other 2 medications.  He stated that there have been other reports of complications after taking the Covid vaccine but there is no information on when I may get over my symptoms.  He gave me a referral to an ENT for an immediate follow up.  I saw the ENT, on 12/28/21.  A separate audiologist gave me a hearing exam and stated my hearing is within the normal range.  She stated that my ears were clear and there was no sign of congestion or problems with my ears and that the hearing test showed a slight difference in my left ear than right but not significant and not the cause of the tinnitus.  She checked my mouth, neck, head and ears.  She found nothing with those checks. She stated my ears are healthy with no congestion or ETD.  She stated that there are other patients also having issues after Covid vaccines.  She stated there is no cure and couldn't tell me if or when the tinnitus will get better as the data regarding the Covid vaccines is too new and incomplete. She gave me a follow up to the ENT MD specialist there at Northwestern  but the closest appointment I could schedule is 5/23/2022.  She also suggested trying white noise and sound masking for relief along with a referral for accupuncture as she stated it has been helpful for some to deal with ongoing  tinnitus.   It is 2/08/2022 and it has been 8 weeks and 3 days since the tinnitus started 1.5 days after getting the Pfizer covid booster shot on 12/10/2021.  The tinnitus has been nonstop in my left ear sometimes in my right.  It has lessened at times but has not gone and sometimes is as loud as the first night.  It seems to increase and decrease in volume randomly.  This has greatly affected my health, wellbeing, and quality of life.  I am hoping it is going down overall over time.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered BUD
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Palpitations, Pharyngeal swelling
Clinical narrative: Throat swelled, Hard time breathing, Heart racing
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Muscle tightness, Muscular weakness, Paraesthesia
Clinical narrative: RN called to the lobby to assess patient. Patient experiencing dizziness after receiving covid and flu vaccine. Patient received covid injection in left deltoid which was pfizer and the booster. A few minutes after the injection, patient got very dizzy which was a room spinning sensation. Per patient, this does occur after injections and blood draws due to the needle. Patient was given apple juice. Patient also complained of a mild headache. Vitals: blood pressure 112/72, heart rate 79 and oxygenation 100%. Patient received vaccine at 1535. At 1600, patient complained of left arm/hand tingling/tight sensation. When asked to squeeze fingers with both hands, left side was weaker and pointer finger did not move to grip writers finger. Denies any chest pain, shortness of breath, throat swelling, and redness at injection site. RN consulted with DO who stated patient should be evaluated in the ER. RN brought patient to the ER and informed staff of symptoms.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: RN called to the lobby to assess patient. Patient experiencing dizziness after receiving covid and flu vaccine. Patient received covid injection in left deltoid which was pfizer and the booster. A few minutes after the injection, patient got very dizzy which was a room spinning sensation. Per patient, this does occur after injections and blood draws due to the needle. Patient was given apple juice. Patient also complained of a mild headache. Vitals: blood pressure 112/72, heart rate 79 and oxygenation 100%. Patient received vaccine at 1535. At 1600, patient complained of left arm/hand tingling/tight sensation. When asked to squeeze fingers with both hands, left side was weaker and pointer finger did not move to grip writers finger. Denies any chest pain, shortness of breath, throat swelling, and redness at injection site. RN consulted with DO who stated patient should be evaluated in the ER. RN brought patient to the ER and informed staff of symptoms.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Adult failure to thrive, Asthenia, Blood pressure increased, COVID-19, Diarrhoea
Clinical narrative: HOSPITAL COURSE: This is a 78 y.o. female with a history of asthma, COPD, BOOP d/t XRT, GERD, breast cancer, HTN, HLD, hypothyroidism, neuropathy, chronic pain syndrome on chronic opiate agonist (Belbuca), OSA, depression and anxiety, recent COVID-19 infection diagnosed 1/3/22 who presented with ongoing weakness, hoarse voice since her Covid infection earlier this month and N/V/D.    Nausea, vomiting, diarrhea Long-haul Covid, possible failure to thrive Clinically seems to have failure to thrive course after COVID-19 infection 1/3/2022 with pre-existing cognitive impairments, chronic pain syndrome, depression/anxiety and frailty. Initially it was reported as N/V/D since her Covid diagnosis although patient reports it started suddenly shortly before admission.  Treated conservatively with supportive cares, IVFs, antiemetics prn and slow diet advancement as she tolerated . Possible viral gastroenteritis.  N/V/D resolved quickly after arrival and she was tolerating a regular diet. C.diff nor enterics were ever collected because diarrhea resolved upon admission.  There were no acute Covid issues during her hospitalization.  Recommended ongoing advancement of her diet as she tolerates and f/u with PCP.     Hypokalemia Likely d/t GI losses, poor oral intake. Replaced during stay.   GERD History of upper GI bleed, gastric ulcers 12/2021 Continue PTA omeprazole 40 mg twice daily. Closely monitored for hematemesis, melena - neither of which occurred. Hgb 10.8 -- > 9 suspected primarily dilutional as 9-10 range is where her Hgb was previously. Ongoing f/u with PCP.   COPD, non-O2 dependent Continued home inhalers: Advair discus, albuterol HFA, DuoNeb, albuterol neb Was not using properly; RT completed education on inhaler use   HTN: BPs controlled, intermittently elevated HLD Continued PTA losartan, Lasix, metoprolol and rosuvastatin   Anxiety/depression Chronic pain syndrome Chronic opiate agonist therapy, Belbuca PTA meds: Tizanidine, gabapentin, sertraline, Belbuca continued   Hypothyroidism Continued levothyroxine    History of breast cancer No acute concerns
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Gastric ulcer, Haemoglobin decreased, Hypokalaemia, Hypophagia
Clinical narrative: HOSPITAL COURSE: This is a 78 y.o. female with a history of asthma, COPD, BOOP d/t XRT, GERD, breast cancer, HTN, HLD, hypothyroidism, neuropathy, chronic pain syndrome on chronic opiate agonist (Belbuca), OSA, depression and anxiety, recent COVID-19 infection diagnosed 1/3/22 who presented with ongoing weakness, hoarse voice since her Covid infection earlier this month and N/V/D.    Nausea, vomiting, diarrhea Long-haul Covid, possible failure to thrive Clinically seems to have failure to thrive course after COVID-19 infection 1/3/2022 with pre-existing cognitive impairments, chronic pain syndrome, depression/anxiety and frailty. Initially it was reported as N/V/D since her Covid diagnosis although patient reports it started suddenly shortly before admission.  Treated conservatively with supportive cares, IVFs, antiemetics prn and slow diet advancement as she tolerated . Possible viral gastroenteritis.  N/V/D resolved quickly after arrival and she was tolerating a regular diet. C.diff nor enterics were ever collected because diarrhea resolved upon admission.  There were no acute Covid issues during her hospitalization.  Recommended ongoing advancement of her diet as she tolerates and f/u with PCP.     Hypokalemia Likely d/t GI losses, poor oral intake. Replaced during stay.   GERD History of upper GI bleed, gastric ulcers 12/2021 Continue PTA omeprazole 40 mg twice daily. Closely monitored for hematemesis, melena - neither of which occurred. Hgb 10.8 -- > 9 suspected primarily dilutional as 9-10 range is where her Hgb was previously. Ongoing f/u with PCP.   COPD, non-O2 dependent Continued home inhalers: Advair discus, albuterol HFA, DuoNeb, albuterol neb Was not using properly; RT completed education on inhaler use   HTN: BPs controlled, intermittently elevated HLD Continued PTA losartan, Lasix, metoprolol and rosuvastatin   Anxiety/depression Chronic pain syndrome Chronic opiate agonist therapy, Belbuca PTA meds: Tizanidine, gabapentin, sertraline, Belbuca continued   Hypothyroidism Continued levothyroxine    History of breast cancer No acute concerns
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Post-acute COVID-19 syndrome, Upper gastrointestinal haemorrhage, Vomiting
Clinical narrative: HOSPITAL COURSE: This is a 78 y.o. female with a history of asthma, COPD, BOOP d/t XRT, GERD, breast cancer, HTN, HLD, hypothyroidism, neuropathy, chronic pain syndrome on chronic opiate agonist (Belbuca), OSA, depression and anxiety, recent COVID-19 infection diagnosed 1/3/22 who presented with ongoing weakness, hoarse voice since her Covid infection earlier this month and N/V/D.    Nausea, vomiting, diarrhea Long-haul Covid, possible failure to thrive Clinically seems to have failure to thrive course after COVID-19 infection 1/3/2022 with pre-existing cognitive impairments, chronic pain syndrome, depression/anxiety and frailty. Initially it was reported as N/V/D since her Covid diagnosis although patient reports it started suddenly shortly before admission.  Treated conservatively with supportive cares, IVFs, antiemetics prn and slow diet advancement as she tolerated . Possible viral gastroenteritis.  N/V/D resolved quickly after arrival and she was tolerating a regular diet. C.diff nor enterics were ever collected because diarrhea resolved upon admission.  There were no acute Covid issues during her hospitalization.  Recommended ongoing advancement of her diet as she tolerates and f/u with PCP.     Hypokalemia Likely d/t GI losses, poor oral intake. Replaced during stay.   GERD History of upper GI bleed, gastric ulcers 12/2021 Continue PTA omeprazole 40 mg twice daily. Closely monitored for hematemesis, melena - neither of which occurred. Hgb 10.8 -- > 9 suspected primarily dilutional as 9-10 range is where her Hgb was previously. Ongoing f/u with PCP.   COPD, non-O2 dependent Continued home inhalers: Advair discus, albuterol HFA, DuoNeb, albuterol neb Was not using properly; RT completed education on inhaler use   HTN: BPs controlled, intermittently elevated HLD Continued PTA losartan, Lasix, metoprolol and rosuvastatin   Anxiety/depression Chronic pain syndrome Chronic opiate agonist therapy, Belbuca PTA meds: Tizanidine, gabapentin, sertraline, Belbuca continued   Hypothyroidism Continued levothyroxine    History of breast cancer No acute concerns
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Epilepsy, Seizure
Clinical narrative: Have Epilepsy  and he has had his seizures under control for over a year. A few days after he received vaccine he started having seizures that came and went for about a month.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID-19 infection resulting in hospitalization.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: C-reactive protein, Full blood count, Urticaria
Clinical narrative: Urticaria
Age: 50.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Injected limb mobility decreased, Injection site pain, Loss of personal independence in daily activities, Magnetic resonance imaging abnormal, Tendon injury
Clinical narrative: Patient complaint of pain in left shoulder and inability to move arm, same day after vaccine given 1/29/2021. Pt reported she couldn't perform activities of daily life. she requested Physical Therapy referral in Feb 2021 which help but pain was not getting better. April 1, 2021 Patient had a left shoulder MRI which showed Left RC tendon and tendonitis as well as a tear noted in MRI.
Age: 50.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Tendonitis, X-ray
Clinical narrative: Patient complaint of pain in left shoulder and inability to move arm, same day after vaccine given 1/29/2021. Pt reported she couldn't perform activities of daily life. she requested Physical Therapy referral in Feb 2021 which help but pain was not getting better. April 1, 2021 Patient had a left shoulder MRI which showed Left RC tendon and tendonitis as well as a tear noted in MRI.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin swelling, Urticaria
Clinical narrative: Hives all over body and face, extreme itching all over body, raised and swollen skin
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered BUD
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Blood creatinine increased, C-reactive protein increased, COVID-19
Clinical narrative: HOSPITAL COURSE: This is a 61 y.o. female with PMHx of hypertension, chronic neck and back pain on chronic opiate agonist therapy (Subutex), anxiety/depression, migraines, autoimmune hepatitis and renal insufficiency, who is double vaccinated with Moderna but overdue for booster presented with fever, cough and shortness of breath starting 1/15.  Tested positive for Covid on admission 1/29.  O2 sats 95% on room air.  Chest x-ray showed bilateral patchy infiltrates.  CTA chest showed pulmonary emboli on the right, without evidence of cor pulmonale or right heart strain.  Started on Eliquis and admitted for further observation and management.   COVID-19 infection Multiple right sided pulmonary emboli Did not require supplemental O2. Sats remained stable on RA at rest and with exertion around the room. Started on dexamethasone on admission, continued this during her stay but no indication for ongoing steroid treatment on d/c. Started on Eliquis with loading and maintenance doses planned (10 mg twice daily for 7 days followed by a 5 mg twice daily). Pharmacy test claim was completed on day of d/c - pending at current time. Discussed with patient. Planning for the first month to be free with subsequent refills per her PCP (if cost-prohibitive then adjustments in anticoagulation therapy should be made through PCP). Procalcitonin 0.04, antibiotics not indicated. CRP 17.9 -- > 6.1. She felt well and felt ready to discharge to home. She was encouraged to continue using the IS. Discussed increased risk of bleeding on blood thinners.  Recommend ~6 months anticoagulation, presuming te PEs were provoked by her underlying COVID-19 infection.  F/u with PCP in 1-2 weeks and ongoing for anticoagulation monitoring and management.    Hypertension BPs controlled. Continued PTA lisinopril 10 mg daily and amlodipine 10 mg daily.    Mild acute renal sufficiency Creatinine 1.16 -- > 0.96.    Chronic pain syndrome with neck and back pain On chronic opiate agonist therapy Anxiety, depression Continued Subutex along with PTA Tizanidine, diazepam, hydroxyzine, pregabalin.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Cough, Dyspnoea, Lung infiltration, Procalcitonin
Clinical narrative: HOSPITAL COURSE: This is a 61 y.o. female with PMHx of hypertension, chronic neck and back pain on chronic opiate agonist therapy (Subutex), anxiety/depression, migraines, autoimmune hepatitis and renal insufficiency, who is double vaccinated with Moderna but overdue for booster presented with fever, cough and shortness of breath starting 1/15.  Tested positive for Covid on admission 1/29.  O2 sats 95% on room air.  Chest x-ray showed bilateral patchy infiltrates.  CTA chest showed pulmonary emboli on the right, without evidence of cor pulmonale or right heart strain.  Started on Eliquis and admitted for further observation and management.   COVID-19 infection Multiple right sided pulmonary emboli Did not require supplemental O2. Sats remained stable on RA at rest and with exertion around the room. Started on dexamethasone on admission, continued this during her stay but no indication for ongoing steroid treatment on d/c. Started on Eliquis with loading and maintenance doses planned (10 mg twice daily for 7 days followed by a 5 mg twice daily). Pharmacy test claim was completed on day of d/c - pending at current time. Discussed with patient. Planning for the first month to be free with subsequent refills per her PCP (if cost-prohibitive then adjustments in anticoagulation therapy should be made through PCP). Procalcitonin 0.04, antibiotics not indicated. CRP 17.9 -- > 6.1. She felt well and felt ready to discharge to home. She was encouraged to continue using the IS. Discussed increased risk of bleeding on blood thinners.  Recommend ~6 months anticoagulation, presuming te PEs were provoked by her underlying COVID-19 infection.  F/u with PCP in 1-2 weeks and ongoing for anticoagulation monitoring and management.    Hypertension BPs controlled. Continued PTA lisinopril 10 mg daily and amlodipine 10 mg daily.    Mild acute renal sufficiency Creatinine 1.16 -- > 0.96.    Chronic pain syndrome with neck and back pain On chronic opiate agonist therapy Anxiety, depression Continued Subutex along with PTA Tizanidine, diazepam, hydroxyzine, pregabalin.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: HOSPITAL COURSE: This is a 61 y.o. female with PMHx of hypertension, chronic neck and back pain on chronic opiate agonist therapy (Subutex), anxiety/depression, migraines, autoimmune hepatitis and renal insufficiency, who is double vaccinated with Moderna but overdue for booster presented with fever, cough and shortness of breath starting 1/15.  Tested positive for Covid on admission 1/29.  O2 sats 95% on room air.  Chest x-ray showed bilateral patchy infiltrates.  CTA chest showed pulmonary emboli on the right, without evidence of cor pulmonale or right heart strain.  Started on Eliquis and admitted for further observation and management.   COVID-19 infection Multiple right sided pulmonary emboli Did not require supplemental O2. Sats remained stable on RA at rest and with exertion around the room. Started on dexamethasone on admission, continued this during her stay but no indication for ongoing steroid treatment on d/c. Started on Eliquis with loading and maintenance doses planned (10 mg twice daily for 7 days followed by a 5 mg twice daily). Pharmacy test claim was completed on day of d/c - pending at current time. Discussed with patient. Planning for the first month to be free with subsequent refills per her PCP (if cost-prohibitive then adjustments in anticoagulation therapy should be made through PCP). Procalcitonin 0.04, antibiotics not indicated. CRP 17.9 -- > 6.1. She felt well and felt ready to discharge to home. She was encouraged to continue using the IS. Discussed increased risk of bleeding on blood thinners.  Recommend ~6 months anticoagulation, presuming te PEs were provoked by her underlying COVID-19 infection.  F/u with PCP in 1-2 weeks and ongoing for anticoagulation monitoring and management.    Hypertension BPs controlled. Continued PTA lisinopril 10 mg daily and amlodipine 10 mg daily.    Mild acute renal sufficiency Creatinine 1.16 -- > 0.96.    Chronic pain syndrome with neck and back pain On chronic opiate agonist therapy Anxiety, depression Continued Subutex along with PTA Tizanidine, diazepam, hydroxyzine, pregabalin.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Gingival pain, Interchange of vaccine products
Clinical narrative: Around 01/10/2022- pain in my gum, on the lower left side at the very back, where I used to have my wisdom tooth.  01/13/2022- I went to see my dentist, he could not see anything, He said there maybe something under the gum and he asked me to use salt water to rinse. After a week after I saw the dentist it resolved. On 01/22/2022- I had the pain in my gum again, this time on the right side lower gum, at the very back. I treated it by rinsing it with salt water and it resolve after 5 to 7 days. Around that time, I started thinking,  could it be related to the vaccine. So when I received the prompt from the smartphone based tool I entered it into the system.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Intense itching on day 11 and 12 after being given the booster and then traveling hives head to toe all over body.  Benadryl and Pepcid for a week with no relief.  Prednisone and hydroxyzine for 8 days with some relief but daily give outbreaks
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Amyotrophic lateral sclerosis, Blood test, Computerised tomogram head, Computerised tomogram neck, Electromyogram
Clinical narrative: Started having ALS symptoms in early to mid-March 2021. Finally diagnosed in August, 2021. No genetic history of ALS. No other reasons.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Magnetic resonance imaging spinal, Urine analysis
Clinical narrative: Started having ALS symptoms in early to mid-March 2021. Finally diagnosed in August, 2021. No genetic history of ALS. No other reasons.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray, Coccidioidomycosis, Computerised tomogram thorax, Hypoaesthesia
Clinical narrative: The same night after receiving the vaccine part of his left hand went numb. That lasted for about a week. In October he was diagnosed with pneumonia and valley fever. He was sick for a month and went to the ER 4 times. He had IV antibiotics and IV fungal when he was hospitalized for 3 days in November. He was prescribed an antibiotic and fluconazole for the valley fever. Last week he caught covid and had a sore throat and congestion.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza virus test, Malaise, Oropharyngeal pain, Pneumonia, Respiratory tract congestion
Clinical narrative: The same night after receiving the vaccine part of his left hand went numb. That lasted for about a week. In October he was diagnosed with pneumonia and valley fever. He was sick for a month and went to the ER 4 times. He had IV antibiotics and IV fungal when he was hospitalized for 3 days in November. He was prescribed an antibiotic and fluconazole for the valley fever. Last week he caught covid and had a sore throat and congestion.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory viral panel, SARS-CoV-2 test positive
Clinical narrative: The same night after receiving the vaccine part of his left hand went numb. That lasted for about a week. In October he was diagnosed with pneumonia and valley fever. He was sick for a month and went to the ER 4 times. He had IV antibiotics and IV fungal when he was hospitalized for 3 days in November. He was prescribed an antibiotic and fluconazole for the valley fever. Last week he caught covid and had a sore throat and congestion.